Read the latest articles and press releases covering OTR.
May 20, 2022Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics
May 9, 2022Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Formulation
April 27, 2022Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo
April 19, 2022Comera Life Sciences and Intas Pharmaceuticals Announce Research Collaboration
April 18, 2022Comera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination
February 4, 2022OTR Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination
January, 31, 2022Comera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp.
December 8, 2020OTR Acquisition Corp. Announces the Separate Trading of Its Class A Common Stock and Warrants, Commencing December 10, 2020
November 19, 2020OTR Acquisition Corp. Announces Closing of $104.5 Million Initial Public Offering, Including Partial Exercise of the Overallotment Option
November 17, 2020OTR Acquisition Corp. Announces Pricing of $100.0 Million Initial Public Offering